• AZD0156: A Better Framework for ATM Assays

  2026-08-17

  AZD0156 is a selective ATM kinase inhibitor for studying how DNA damage signaling, repair, and checkpoint control shape cancer-cell responses. This guide adds an assay-design framework that connects target engagement with functional and translational readouts.

• Acridine Orange hydrochloride: Practical Staining Guide

  2026-08-17

  Acridine Orange hydrochloride is a cell- and organelle-permeable fluorescent nucleic acid dye for distinguishing DNA-associated green fluorescence from RNA or single-stranded nucleic acid-associated red fluorescence. It is suitable for cell cycle analysis, apoptosis detection, and flow-based nucleic acid workflows, but assay-specific settings must be validated and prepared solutions should not be stored long term.

• Phillygenin in Diabetic Nephropathy: Mechanistic Evidence

  2026-08-16

  A 2025 Phytomedicine study identifies phillygenin as a preclinical candidate for diabetic nephropathy and connects its renal protective effects with suppression of TLR4/MyD88/NF-κB signaling and restoration of PI3K/AKT/GSK3β-associated survival signaling. Its integrated podocyte, transcriptomic, biochemical, and db/db mouse experiments provide a useful framework for studying inflammation, apoptosis, and proteinuria in diabetic kidney disease.

• Diuron Workflows for Plant and Toxicology Research

  2026-08-15

  Diuron supports two complementary research paths: controlled photosynthesis-inhibitor assays in plant systems and mechanistic toxicology studies in mammalian cells. This workflow-focused guide connects solvent handling, dose-response design, JAK2/STAT1 validation, and troubleshooting for more reproducible experiments.

• 7ACC2: Monocarboxylate Transporter 1 Inhibitor

  2026-08-14

  7ACC2 is a nanomolar carboxycoumarin tool for separating lactate uptake, pyruvate transport, and downstream metabolic stress in tumor models. Its value extends beyond viability testing: carefully staged transport assays can connect cancer-cell metabolism with the immunosuppressive tumor microenvironment while preserving clear experimental boundaries.

• Plerixafor (AMD3100): CXCR4 Research Guide

  2026-08-14

  Plerixafor, also called AMD3100, is a small-molecule CXCR4 antagonist that disrupts CXCL12/SDF-1 signaling. It supports mechanistic studies of cancer metastasis inhibition, hematopoietic stem cell mobilization, neutrophil trafficking, and WHIM syndrome treatment research.

• BMS-345541 hydrochloride: IKK Inhibitor Workflows

  2026-08-13

  BMS-345541 hydrochloride enables selective NF-κB pathway interrogation across inflammation research, T-cell acute lymphoblastic leukemia models, and translational airway-stent assays. This guide connects pathway-level target engagement with practical dose design, conditioned-medium experiments, apoptosis measurements, and troubleshooting for solubility and timing artifacts.

• Dihydrotestosterone Workflows for AR Research

  2026-08-13

  Dihydrotestosterone (DHT) provides a direct, tunable way to interrogate androgen receptor signaling, from EGFR–AKT responses in bladder cancer cells to muscle and neurodegeneration models. This workflow-focused guide connects concentration control, phosphoprotein timing, and orthogonal validation with the androgen and TGF-β/Smad findings reported in a recent prostate research study.

• BRCA2, PARP1 Retention, and RAD51 Filament Protection

  2026-08-12

  The 2025 Nature study identifies PARP inhibitor-induced PARP1 retention on resected DNA as a direct threat to RAD51 filament stability, and shows that full-length BRCA2 prevents this interference. Its biochemical, single-molecule, and cellular evidence clarifies why BRCA2-deficient tumors are especially vulnerable to PARP inhibition and provides a mechanistic framework for DNA repair deficiency targeting.

• Plerixafor (AMD3100) for CXCR4 Research

  2026-08-12

  Plerixafor (AMD3100) provides a reversible way to interrogate CXCL12/CXCR4 signaling in tumor, stem-cell, and immune-cell workflows. This guide translates the reference study’s platelet-extravasation findings into practical assay designs, formulation choices, and troubleshooting strategies.

• ATP Solution (100 mM) for Assay Decision-Making

  2026-08-11

  Discover how ATP Solution supports kinase, transcription, ligation, and phosphorylation workflows while avoiding overinterpretation of assay results. This guide connects ATP chemistry with practical quality controls and the p21 mRNA-LNP bladder cancer study.

• Hexa-Acylated LPS and Cancer Immunotherapy

  2026-08-11

  A Nature Microbiology study identifies the structure of gut microbiota-derived lipopolysaccharide (LPS), rather than bacterial taxonomy alone, as a functional determinant of anti-PD-1 response. Using human metagenomics, cellular assays, and mouse tumor models, the authors show that hexa-acylated LPS activates TLR4-dependent immunity and can enhance checkpoint inhibitor efficacy.

• Aurora A, SAM Metabolism, and Trained Immunity

  2026-08-10

  Li et al. identify Aurora kinase A as a regulator of β-glucan-trained immunity that connects mTOR–FOXO3–GNMT signaling with endogenous S-adenosylmethionine availability and histone methylation. Their integrated chromatin, transcriptomic, metabolomic, cellular, and animal experiments show that AurA inhibition weakens inflammatory recall and removes the tumor-suppressive effect of trained immunity in mice.

• BMN 673: PARP Trapping in DNA Repair Studies

  2026-08-09

  BMN 673 (Talazoparib) combines exceptionally potent PARP1/2 inhibition with strong PARP-DNA complex trapping, making it a useful probe for DNA repair deficiency and synthetic-lethality experiments. This guide translates spliceosome-focused hepatocellular carcinoma findings into practical viability, mechanistic, combination, and troubleshooting workflows.

• Streptavidin-Cy3 for NPC Metastasis Assays

  2026-08-08

  Streptavidin-Cy3 converts biotinylated antibodies and nucleic-acid probes into bright, spatially resolved readouts for nasopharyngeal carcinoma research. This guide connects the seRNA-NPCm mechanism to practical IHC, IF, ISH, and flow cytometry workflows while emphasizing controls, titration, and troubleshooting.

11584 records 1/773 page Next 12345 下5页 Last page